HY2Care key facts
- Manufacturer of an injectable hydrogel designed to repair cartilage defects.
- It has raised $9.2M; the latest was Later Stage VC ($5.0M) in May 2025.
- Notable investors include European Innovation Council, Startupbootcamp Holding, Limburg Development and Investment Company, Brightlands Venture Partners, DutchBasecamp — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch HY2Care: the Monday email on marks, rounds and moves
HY2Care funding rounds
No funding rounds for HY2Care are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
HY2Care investors
8 investors are on record for HY2Care, including European Innovation Council, Startupbootcamp Holding, Limburg Development and Investment Company and Brightlands Venture Partners.
About HY2Care
Manufacturer of an injectable hydrogel designed to repair cartilage defects. The company's two-component injectable and bioresorbable hydrogel are composed of a mixture of natural polymer conjugates that cross-link in a mild enzymatic reaction, enabling clinicians to treat patients with functional repair of cartilage defects in the knee.
- Sector
- Healthcare
- HQ
- Geleen, Netherlands
- Founded
- 2014
- Employees
- 12
- Website
- hy2care.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
HY2Care doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.